首页> 美国卫生研究院文献>Research and Practice in Thrombosis and Haemostasis >Protease‐activated receptors: An illustrated review
【2h】

Protease‐activated receptors: An illustrated review

机译:蛋白酶激活受体:说明的审查

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Proteases are important regulators of cell behavior, survival, and apoptosis. They communicate to cells directly through a special class of G‐protein–coupled receptors known as protease‐activated receptors (PARs). N‐terminal PAR proteolysis unmasks a neo‐N‐terminus, which serves as a tethered ligand to activate PARs. Using this unique irreversible activation mechanism, PARs relay information across cell membranes. The year 2020 is the 30th year since discovery of the first member of this family, PAR1. In this illustrated review, we highlight achievements in the PAR field over the past 3 decades. Additionally, the known expression profiles of PARs in human tissues and across species are portrayed. We also illustrate the tethered ligand activation mechanism, which is unique to PARs, and PAR regulatory mechanisms. PAR1 was originally named “thrombin receptor” because thrombin was the first protease identified to activate PAR1. However, over the past 30 years, a growing number of proteases have been found to cleave PARs and trigger differential downstream signaling depending on cleavage site, cell type, and species. We exemplify the diversity of PAR1‐mediated signaling outcomes in platelets and endothelial cells as pertinent examples to the hemostasis, thrombosis, and vascular biology fields. Further, the termination and regulation of PAR signaling via endocytosis and currently available pharmacologic approaches are depicted. We conclude with portrayal of clinically translational aspects of PAR biology including pharmacologic manipulation and single‐nucleotide polymorphisms.
机译:蛋白酶是细胞行为,生存和凋亡的重要调节因素。它们通过一种称为蛋白酶活化受体(PARS)的特殊类G蛋白偶联受体直接与细胞通信。 N-末端par蛋蛋白溶解Unmasks是一种新N-末端,其用作束缚配体以激活帕氏菌。使用这种独特的不可逆激活机制,在细胞膜上解析中继信息。 2020年年是从发现这个家庭的第一个成员的第30岁,PAR1。在本说明的审查中,我们突出了过去三十年来突出了Par领域的成就。另外,描绘了人组织和跨物种中的已知表达谱。我们还说明了束缚配体激活机制,其是对解析的独特性和调节机制。 PAR1最初被命名为“凝血酶受体”,因为凝血酶是鉴定为激活PAR1的第一种蛋白酶。然而,在过去30年中,已发现越来越多的蛋白酶根据裂解位点,细胞类型和物种裂开分析并触发差分下游信号。我们举例说明了血小板和内皮细胞中PAR1介导的信号分量的分集,以及止血,血栓形成和血管生物领域的相关实例。此外,描绘了通过内吞作用和目前可用的药理学方法的PAR信号传导的终止和调节。我们得出结论,对临床翻译方面的临床翻译方面,包括药理操纵和单核苷酸多态性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号